Navigation Links
Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

t is being prepared.

?These three Phase II clinical trials sponsored by NCI are components of a clinical trials program designed to identify signals of clinical activity of ispinesib across multiple tumor types,? stated Dr. Andrew A. Wolff, Cytokinetics Senior Vice President of Clinical Research and Development and Chief Medical Officer. ?Although these three trials did not meet the protocol-specified criteria for progression, we are encouraged by the anti-cancer activity of ispinesib observed to date in three other Phase II trials in breast, ovarian and non-small cell lung cancers. Based on these data, we plan to move forward in further clinical development of ispinesib with a focused approach to the potential treatment of breast cancer with ispinesib.?

Clinical Trials of Ispinesib

Ispinesib has been the subject of a broad Phase II clinical trials program under the sponsorship of GlaxoSmithKline (GSK) and is also being developed in collaboration with the NCI. GSK has sponsored three Phase II clinical trials, one evaluating ispinesib as second- or third-line treatment for patients with locally advanced or metastatic breast cancer, one evaluating ispinesib as second-line treatment for patients with non-small cell lung cancer, and one evaluating ispinesib as second-line treatment for patients with advanced ovarian cancer. Enrollment in all of these trials has been closed. To date, clinical activity with ispinesib has been observed in breast cancer, in non-small cell lung cancer, and ovarian cancer with the more robust clinical activity observed in a Phase II clinical trial evaluating ispinesib in the treatment of metastatic breast cancer patients that have failed treatment with taxanes and anthracyclines. In this clinical trial, The best overall responses observed with ispinesib were partial responses in 4 of 45 evaluable patients as measured by the RECIST criteria. Responses were confirmed by independent radiology review and were seen in
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:11/21/2014)... FALLS, N.J. , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. ... A. Krakauer , Chief Executive Officer, will be presenting at ... The New York Palace Hotel in New York ... 2, 2014 at 2:00 PM ET. In addition, Mr. Krakauer ... be available for separate one-on-one meetings during the day. ...
(Date:11/21/2014)... , Nov. 20, 2014  The acceptance of ... 2014 AAGL Global Congress demonstrates continued interest in ... to provide bowel control. One of the abstracts, presented ... and Division Chief of Urogynecology and Reconstructive Pelvic ... an Award for Best Written Abstract on Urogynecology/Pelvic ...
(Date:11/21/2014)... Fla. , Nov. 20, 2014   Coqui ... become the first U.S. commercial producer of Molybdenum-99 (Mo-99), ... contract with INVAP to design its Medical ... Mo-99 is the parent isotope of Technetium-99, ... procedures worldwide. In 2012, Congress passed legislation making it ...
Breaking Medicine Technology:LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2
... -- PharmacyGPO, Inc.,  a pharmacy buying group ... States, today announced a three-year agreement with H. ... (Photo: http://photos.prnewswire.com/prnh/20120507/CG01217 ) Under the ... leading national wholesaler, will be the exclusive supplier ...
... Popular online pharmacy Edens RX ( www.EdensRX.com ) is pleased to ... the month of May. In recognition of Armed Services ... of all the service men and women returning home, military personnel ... to receive $15 off their order. EdensRX.com is known ...
Cached Medicine Technology:PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor 2PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor 3
(Date:11/21/2014)... 20, 2014 (HealthDay News) -- Seeking to make it ... Food and Drug Administration on Thursday approved a new ... Hydrocodone -- best known by the brand name Vicodin ... tied to a surge in dangerous addictions across the ... Hysingla ER (hydrocodone bitartrate) is an extended-release tablet to ...
(Date:11/21/2014)... Scientists say they,ve mapped the genome -- the genetic "blueprint" ... in hopes it might help others with this very rare ... Genome Biology , the tapeworm was removed from the brain ... infection is so rare worldwide and completely unexpected in this ... worm was pulled out from the brain," study lead author ...
(Date:11/21/2014)... and WOBURN, Mass. (PRWEB) November 21, 2014 ... present two free workshops titled “Massachusetts Insurance Funding for ... spectrum disorder (ASD) navigate their way through the insurance ... be covered under Massachusetts law and the most effective ... place on Thursday, Dec. 4 from 6-8:00 p.m. at ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Big Bud ... an upcoming episode of Innovations with Ed Begley Jr., ... show times TBA. , Big Bud Farms, growers of ... growing, harvesting, and utilization of medical marijuana. , This ... Bud Farms’ wide variety of products for medicating. Viewers ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Launched today ... (ECA) is an all-in-one senior care coordination tool designed ... loved ones simple and intuitive for family members and ... care centers). Now, the family caregiver or home health ... daily activities, health data, medical records, goals, schedules, and ...
Breaking Medicine News(10 mins):Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 2Health News:FDA Approves 'Abuse-Resistant' Narcotic Painkiller 3Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:Center for Autism and Related Disorders to Host Massachusetts Autism Insurance Workshops for Parents 2Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Comprehensive Senior Care Application Launched on Apple App Store 2
... Abercrombie, president and,chief executive officer, Hoffmann-La Roche ... the National Association of Corporate,Directors-Southern California Chapter ... the threat of a pandemic flu presents ... emergency preparedness plans., "While many business ...
... likely to bully others, get into fights , , WEDNESDAY, Oct. ... minimal exposure to violent entertainment in the media are far ... suggests. , "We,re looking at a slice in time, so ... violent behavior, or in the reverse that violent kids are ...
... millions of Americans gear up for the Thanksgiving holiday, ... FASEB Journal ( http://www.fasebj.org ), may provide some ... In the report, researchers describe a discovery that ... problems without actually losing weight: they make a common ...
... The American Journal of Nursing (AJN) announced ... Caregiver Award is being given to Jean and Ric ... and generosity to nursing. The Award, recognizing individuals ... nurses and excellence in nursing practice, was presented on ...
... CEO John G. Schulte with Chairman ... Emile J. Geisenheimer., ... lawsuit on behalf of those who purchased Spectranetics Company,stock (Nasdaq: ... officer violated U.S. securities laws through illegal,marketing practices and false statements ...
... and Online Content to Fight,Mental Health Stigma and ... YORK, Oct. 29 mtvU, MTV,s 24-hour college ... to reduce emotional,distress and prevent suicide among college ... campaign with new content launching,today that encourages students ...
Cached Medicine News:Health News:CEO to Address Los Angeles Business Leaders About Developing Pandemic and Business Continuity Plans 2Health News:CEO to Address Los Angeles Business Leaders About Developing Pandemic and Business Continuity Plans 3Health News:Less Exposure to Violent Media Makes Youths Less Aggressive 2Health News:Less Exposure to Violent Media Makes Youths Less Aggressive 3Health News:New drug target in obesity: Fat cells make lots of melanin 2Health News:The American Journal of Nursing honors Jean and Ric Edelman 2Health News:The American Journal of Nursing honors Jean and Ric Edelman 3Health News:Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics 2Health News:Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics 3Health News:Hagens Berman Sobol Shapiro: Class Action Filed Against Spectranetics 4Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 2Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 3Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 4Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 5Health News:mtvU and The Jed Foundation Ask Students 'How Are You A Friend?' 6
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Compact, economical Bactron II anaerobic environment system with air lock, workspace and a 200 plate capacity incubator delivers optimum productivity in a compact space....
... an ideal first anaerobic chamber. ... smaller laboratories, it can also ... station for larger labs. All ... Bactron models are standard (excluding ...
... 400-M incorporates all the familiar and proven features ... interface with the Ruskinn patented gas mixing system.The ... (0.1% - 20% in 0.1% increments), carbon dioxide ... (0% - 10% in 1% increments) components of ...
Medicine Products: